---
title: Cedars-Sinai invests in Neolook – first US institutional investor
description: Neolook Solutions secures USD 525.000 from Cedars-Sinai Medical Center via Post-Money SAFE at a USD 7.5M valuation cap – the first US institutional investment in Neolook, with a linked Milestone Equity Agreement tied to clinical trial, health economics, and FDA readiness.
image: https://www.neolooksolutions.com/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png
---

[Zu Content springen](https://www.neolooksolutions.com/de/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor#main-content)

![Neolook_logo_RGB_FCMark-1](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook_logo_RGB_FCMark-1.png?width=200&height=152&name=Neolook_logo_RGB_FCMark-1.png "Neolook_logo_RGB_FCMark-1")

Neolook

Uniting those who care

Digital eyes and ears on the child in intensive care.

Always.

Deutsch

- [Nederlands](https://www.neolooksolutions.com/nl/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor)
- [English](https://www.neolooksolutions.com/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor)
- [Deutsch](https://www.neolooksolutions.com/de/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor)

[Contact us](https://www.neolooksolutions.com/contact-us?hsLang=de)

[Home](https://www.neolooksolutions.com/?hsLang=de)

[Products](https://www.neolooksolutions.com/products?hsLang=de)

[Plans](https://www.neolooksolutions.com/plans?hsLang=de)

[Enquiry](https://www.neolooksolutions.com/enquiry?hsLang=de)

[Media](https://www.neolooksolutions.com/media?hsLang=de)

[Blog](https://www.neolooksolutions.com/blog?hsLang=de)

[About Us](https://www.neolooksolutions.com/about-us?hsLang=de)

Dies ist ein Suchfeld mit einer automatischen Vorschlagsfunktion.

- Es gibt keine Vorschläge, da das Suchfeld leer ist.

 11 November 2025

# Cedars-Sinai invests in Neolook – first US institutional investor

[Marco D'Agata](https://www.neolooksolutions.com/de/blog/author/marco-dagata)

Teilen: [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://www.neolooksolutions.com/de/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor) [envelope icon](mailto:?body=https://www.neolooksolutions.com/de/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor)

Neolook Solutions B.V., the Dutch neonatal digital health company, has secured USD 525.000 from Cedars-Sinai Medical Center (Los Angeles, California) via a Post-Money SAFE at a USD 7,5 million valuation cap. The investment constitutes Neolook Round 3 and makes Cedars-Sinai the first US institutional investor in the company.

The commitment is the direct outcome of a structured three-track international expansion programme executed by Neolook across 2024 and 2025. In the Middle East, Neolook was selected as 1 of 6 startups for the Anjal Z Techstars Founder Catalyst programme (Cohort 05) from 264 global applicants, backed by the Abu Dhabi Early Childhood Authority. In Southeast Asia, Neolook activated a market entry track via Invest International, the Dutch government's internationalisation instrument. In the United States, the ScaleNL programme created the institutional pipeline that led directly to the Cedars-Sinai relationship.

The investment is structured as a Post-Money SAFE with a 20 % discount and includes a linked Milestone Equity Agreement. The milestone equity component grants Cedars-Sinai additional rights conditional on three deliverables: a clinical trial, a health economic study and a demonstrated FDA readiness pathway. Cedars-Sinai becomes Neolook's first US reference site and a co-development partner on the clinical and regulatory evidence required for US market entry.

[Venture](https://www.neolooksolutions.com/de/blog/tag/venture)

## Verwandte Beiträge

[![](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png?height=200&name=Neolook%20Logo%20Large%20FC%201160x263.png)](https://www.neolooksolutions.com/de/blog/neolook-single-source-eu-mdr-position-neolook-one-and-neolook-mira?hsLang=de)

[Venture](https://www.neolooksolutions.com/de/blog/tag/venture)

## [Neolook extends single-source EU MDR position: Neolook One and Mira smart sensorheads](https://www.neolooksolutions.com/de/blog/neolook-single-source-eu-mdr-position-neolook-one-and-neolook-mira?hsLang=de)

[Marco D'Agata](https://www.neolooksolutions.com/de/blog/author/marco-dagata) 

 16 März 2026

Neolook achieved MDR CE for both the Neolook One – its high end smart sensorhead with modular...

[Weiterlesen](https://www.neolooksolutions.com/de/blog/neolook-single-source-eu-mdr-position-neolook-one-and-neolook-mira?hsLang=de)

[![](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png?height=200&name=Neolook%20Logo%20Large%20FC%201160x263.png)](https://www.neolooksolutions.com/de/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen?hsLang=de)

[Venture](https://www.neolooksolutions.com/de/blog/tag/venture)

## [Cry Detection AI 1.0 clears first clinical acceptance gate at Radboudumc – Nijmegen](https://www.neolooksolutions.com/de/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen?hsLang=de)

[Marco D'Agata](https://www.neolooksolutions.com/de/blog/author/marco-dagata) 

 9 Dezember 2022

In August 2022, Neolook's Cry Detection 1.0 prototype passed a formal acceptance-test protocol at...

[Weiterlesen](https://www.neolooksolutions.com/de/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen?hsLang=de)

[![](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook3winspicture.png?height=200&name=Neolook3winspicture.png)](https://www.neolooksolutions.com/de/blog/news/neolook-wins-3-international-growth-programs?hsLang=de)

[Achievement](https://www.neolooksolutions.com/de/blog/tag/achievement)

## [3 Growth Programs for USA, MI and EU](https://www.neolooksolutions.com/de/blog/news/neolook-wins-3-international-growth-programs?hsLang=de)

[Marco D'Agata](https://www.neolooksolutions.com/de/blog/author/marco-dagata) 

 2 Oktober 2024

Born in 2020, after four yours of dedicated work-work-work, we are happily surprised by being noted...

[Weiterlesen](https://www.neolooksolutions.com/de/blog/news/neolook-wins-3-international-growth-programs?hsLang=de)

#### Our Services

- [Home](https://www.neolooksolutions.com)
- [Products](https://www.neolooksolutions.com/products)
- [Plans](https://www.neolooksolutions.com/plans)
- [Media](https://www.neolooksolutions.com/media)
- [Blog](https://www.neolooksolutions.com/blog)

#### Get In Touch

- [Contact](https://www.neolooksolutions.com/contact-us)
- [Enquiries](https://www.neolooksolutions.com/enquiry)
- [Investors](https://www.neolooksolutions.com/investors)

#### Regulatory

- [Code of Conduct](https://www.neolooksolutions.com/cookie-statement)
- [Terms and Conditions](https://www.neolooksolutions.com/terms-and-conditions)
- [Privacy Statement](https://www.neolooksolutions.com/privacy-statement)
- [Cookie Statement](https://www.neolooksolutions.com/cookie-statement)
- [Disclaimer](https://www.neolooksolutions.com/disclaimer)

Neolook Solutions BV   
Princetonlaan 6, 3584 CB Utrecht  
The Netherlands   
Chamber of Commerce 77050797 

 

 

Copyright © 2020-2026, Neolook Solutions

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Marco D'Agata",
    "url" : "https://www.neolooksolutions.com/de/blog/author/marco-dagata"
  },
  "dateModified" : "2026-05-03T09:49:14.707Z",
  "datePublished" : "2025-11-11T10:00:00.000Z",
  "headline" : "Cedars-Sinai invests in Neolook – first US institutional investor",
  "image" : [ "https://www.neolooksolutions.com/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://www.neolooksolutions.com/de/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.neolooksolutions.com/hubfs/Neolook_logo_RGB_FCMark-1.png"
    },
    "name" : "Neolook Solutions"
  }
}
```